BioCentury
ARTICLE | Company News

Avecia Group plc, PharmAthene deal

April 7, 2008 7:00 AM UTC

PharmAthene completed its previously announced acquisition of Avecia's biodefense vaccines business for $10 million at closing, $7 million within 18 months of closing, and up to $23 million in milesto...